Related Experiment Video

Updated: Aug 8, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.2K

Impact of COVID-19 on Acute Myocardial Infarction Care

Raviteja R Guddeti1, Mehmet Yildiz2, Keshav R Nayak3

  • 1Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA.

Heart Failure Clinics
|March 2, 2023
PubMed

Insights

The COVID-19 pandemic significantly reduced hospital admissions for acute myocardial infarction (MI) and related treatments. Factors like lockdowns and fear of infection altered acute MI care delivery globally.

Area of Science:

  • Cardiology
  • Public Health
  • Infectious Diseases

Background:

  • The COVID-19 pandemic caused unprecedented strain on global healthcare systems.
  • Significant reductions in hospital admissions for acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI) were observed worldwide.
  • This phenomenon impacted the management and delivery of acute myocardial infarction (MI) care.

Purpose of the Study:

  • To review the multifaceted impact of the COVID-19 pandemic on acute myocardial infarction (MI) care.
  • To explore the reasons behind the observed changes in healthcare delivery during the pandemic.
  • To highlight the implications for cardiovascular patient management.

Main Methods:

  • Literature review and synthesis of existing data.
  • Analysis of reported trends in hospital admissions for ACS and PCI.
  • Discussion of contributing factors to altered healthcare access and delivery.

Main Results:

  • A substantial and rapid decline in hospital admissions for acute MI and PCI procedures was reported globally.
  • Key contributing factors included public lockdowns, reduced outpatient services, patient fear of viral transmission, and restrictive hospital policies.
  • These changes significantly affected the continuity and accessibility of essential cardiovascular care.

Conclusions:

  • The COVID-19 pandemic profoundly disrupted acute myocardial infarction (MI) care pathways.
  • Understanding these disruptions is crucial for mitigating future impacts on cardiovascular health.
  • Strategies are needed to ensure resilient healthcare systems capable of managing both pandemics and critical cardiovascular conditions.

Keywords:
COVID-19Fibrinolytic therapyMyocardial infarctionNSTEMIPercutaneous coronary interventionSTEMI

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
23
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17